{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:31:31Z","timestamp":1773739891592,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bulcan.2024.06.001","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T11:33:12Z","timestamp":1724844792000},"page":"955-966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Th\u00e9rapies cibl\u00e9es et immunoth\u00e9rapie\u00a0: positionnement dans le champ de l\u2019innovation et enjeux pour le processus de d\u00e9cision th\u00e9rapeutique"],"prefix":"10.1016","volume":"111","author":[{"given":"Carole","family":"El Chami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Meunier-Beillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Binquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00f4me","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2024.06.001_bib0250","series-title":"Le cancer\u00a0: un regard sociologique [Internet]","first-page":"87","article-title":"6. La m\u00e9decine personnalis\u00e9e en canc\u00e9rologie\u00a0: vers une complexification des strat\u00e9gies th\u00e9rapeutiques\u00a0?","author":"Darrason","year":"2018"},{"issue":"10229","key":"10.1016\/j.bulcan.2024.06.001_bib0255","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0140-6736(20)30164-1","article-title":"Small molecules, big impact: 20\u00a0years of targeted therapy in oncology","volume":"395","author":"Bedard","year":"2020","journal-title":"Lancet Lond Engl"},{"issue":"3","key":"10.1016\/j.bulcan.2024.06.001_bib0260","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/antib9030034","article-title":"Monoclonal antibodies in cancer therapy","volume":"9","author":"Zahavi","year":"2020","journal-title":"Antibodies Basel Switz"},{"issue":"7","key":"10.1016\/j.bulcan.2024.06.001_bib0265","first-page":"452","article-title":"Cancer immunotherapy, part 2: efficacy, safety, and other clinical considerations","volume":"42","author":"Ventola","year":"2017","journal-title":"Pharm Ther"},{"issue":"1","key":"10.1016\/j.bulcan.2024.06.001_bib0270","article-title":"Fondements th\u00e9oriques et importance de l\u2019innovation\u00a0: regards des auteurs au cours des ann\u00e9es","volume":"2","author":"Yakoub","year":"2021","journal-title":"Rev Int Cherch [Internet]"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0275","series-title":"Sociologie de l\u2019innovation","author":"G\u00e9rald","year":"2011"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0280","series-title":"Diffusion of innovation. 4e \u00e9d","author":"Rogers","year":"1995"},{"issue":"2","key":"10.1016\/j.bulcan.2024.06.001_bib0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1037\/a0036834","article-title":"Decision making and cancer","volume":"70","author":"Reyna","year":"2015","journal-title":"Am Psychol"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0290","unstructured":"\u00c9l\u00e9ments pour \u00e9laborer une aide \u00e0 la prise de d\u00e9cision partag\u00e9e entre patient et professionnel de sant\u00e9 [Internet]. Haute Autorit\u00e9 de sant\u00e9. [cit\u00e9 23\u00a0avr 2024. Disponible sur\u00a0: https:\/\/www.has-sante.fr\/jcms\/c_2838959\/fr\/elements-pour-elaborer-une-aide-a-la-prise-de-decision-partagee-entre-patient-et-professionnel-de-sante]."},{"key":"10.1016\/j.bulcan.2024.06.001_bib0295","unstructured":"M\u00e9decine de pr\u00e9cision\u00a0: les th\u00e9rapies cibl\u00e9es\u00a0\u2013\u00a0Les th\u00e9rapies cibl\u00e9es. [Internet. Cit\u00e9 8\u00a0nov 2022. Disponible sur\u00a0: https:\/\/www.e-cancer.fr\/Professionnels-de-sante\/Les-therapies-ciblees\/Medecine-de-precision-les-therapies-ciblees]."},{"issue":"1","key":"10.1016\/j.bulcan.2024.06.001_bib0300","first-page":"27","article-title":"La loi du 4\u00a0mars 2002\u00a0dite \u00ab\u00a0loi Kouchner\u00a0\u00bb","volume":"42","author":"Cardin","year":"2014","journal-title":"Trib Sante"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0305","article-title":"Where are the patients in decision-making about their own care? WHO 2008 WHO Behalf","author":"Coulter","year":"2008","journal-title":"Eur Obs Health Syst Policies"},{"issue":"12","key":"10.1016\/j.bulcan.2024.06.001_bib0310","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1377\/hlthaff.2011.0923","article-title":"New 2011\u00a0survey of patients with complex care needs in eleven countries finds that care is often poorly coordinated","volume":"30","author":"Schoen","year":"2011","journal-title":"Health Aff Proj Hope"},{"issue":"2","key":"10.1016\/j.bulcan.2024.06.001_bib0315","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00520-008-0505-2","article-title":"Decision making and quality of life in the treatment of cancer: a review","volume":"17","author":"Zafar","year":"2009","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2024.06.001_bib0320","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrd3715","article-title":"Defining rewardable innovation in drug therapy","volume":"11","author":"Aronson","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.bulcan.2024.06.001_bib0325","first-page":"e4","article-title":"Toward a definition of pharmaceutical innovation","volume":"2","author":"Morgan","year":"2008","journal-title":"Open Med Peer-Rev Indep Open-Access J"},{"issue":"5","key":"10.1016\/j.bulcan.2024.06.001_bib0330","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/intqhc\/mzl034","article-title":"A multi-dimensional model of clinical utility","volume":"18","author":"Smart","year":"2006","journal-title":"Int J Qual Health Care J Int Soc Qual Health Care"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0335","doi-asserted-by":"crossref","first-page":"b5493","DOI":"10.1136\/bmj.b5493","article-title":"NICE and new: appraising innovation","volume":"340","author":"Ferner","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0340","series-title":"Innovation m\u00e9dicamenteuse en canc\u00e9rologie\/\u00e9tude internationale sur la d\u00e9finition et l\u2019acc\u00e8s \u00e0 l\u2019innovation","year":"2018"},{"issue":"4","key":"10.1016\/j.bulcan.2024.06.001_bib0345","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bulcan.2016.03.002","article-title":"M\u00e9dicaments du cancer\u00a0: quelles innovations et \u00e0 quel prix\u00a0?","volume":"103","author":"Gon\u00e7alves","year":"2016","journal-title":"Bull Cancer (Paris)"},{"issue":"7","key":"10.1016\/j.bulcan.2024.06.001_bib0350","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.46747\/cfp.6807e199","article-title":"Therapies cibl\u00e9es contre le cancer\u00a0: perles cliniques \u00e0 l\u2019intention des soins primaires","volume":"68","author":"Shuel","year":"2022","journal-title":"Can Fam Physician Med Fam Can"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0355","first-page":"8","article-title":"M\u00e9decine personnalis\u00e9e\u00a0\u2013\u00a0Un concept flou, des pratiques diversifi\u00e9es","volume":"30","author":"Bateman","year":"2014","journal-title":"Med Sci"},{"issue":"2","key":"10.1016\/j.bulcan.2024.06.001_bib0360","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3917\/mult.075.0072","article-title":"De la m\u00e9decine personnalis\u00e9e \u00e0 l\u2019exposomique. Environnement et sant\u00e9 \u00e0 l\u2019\u00e8re des big data","volume":"75","author":"Guchet","year":"2019","journal-title":"Multitudes"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0365","unstructured":"StatPearls [Internet]. [cit\u00e9 28\u00a0janv 2024. Disponible sur\u00a0: https:\/\/www.statpearls.com\/]."},{"issue":"1","key":"10.1016\/j.bulcan.2024.06.001_bib0370","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.therap.2022.11.011","article-title":"Les essais plateformes","volume":"78","author":"Roustit","year":"2023","journal-title":"Therapie"},{"issue":"12","key":"10.1016\/j.bulcan.2024.06.001_bib0375","first-page":"1043","article-title":"Les immunoconjugu\u00e9s en oncologie\u00a0\u2013\u00a0Les nouvelles strat\u00e9gies en d\u00e9veloppement","volume":"35","author":"Beck","year":"2019","journal-title":"Med Sci"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0380","series-title":"\u00ab\u202fL\u2019accessibilit\u00e9 financi\u00e8re et g\u00e9ographique des soins de sant\u00e9\u202f\u00bb, dans Panorama des administrations publiques 2017","year":"2017"},{"issue":"3","key":"10.1016\/j.bulcan.2024.06.001_bib0385","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3917\/rfs.613.0405","article-title":"Utiliser la recherche pour soigner le cancer\u00a0: l\u2019innovation biom\u00e9dicale localis\u00e9e","volume":"61","author":"Besle","year":"2020","journal-title":"Rev Fr Sociol"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0390","unstructured":"Innovation et syst\u00e8me de sant\u00e9\u00a0\u2013\u00a0Rapport 2016 [Internet]. [Cit\u00e9 28\u00a0janv 2024. Disponible sur\u00a0: https:\/\/www.vie-publique.fr\/sites\/default\/files\/rapport\/pdf\/184000366.pdf]."},{"key":"10.1016\/j.bulcan.2024.06.001_bib0395","article-title":"L\u2019innovation th\u00e9rapeutique\u202f: un enjeu de sant\u00e9 publique, un challenge pour les acteurs du monde de la sant\u00e9","author":"Joanie del","year":"2017","journal-title":"Sciences pharmaceutiques"},{"issue":"3","key":"10.1016\/j.bulcan.2024.06.001_bib0400","first-page":"53","article-title":"Regulating the therapeutic relevance of early phase clinical trials in oncology","author":"Auroy","year":"2019","journal-title":"Rev Fr Aff Soc"},{"issue":"2","key":"10.1016\/j.bulcan.2024.06.001_bib0405","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1470-2045(06)70576-9","article-title":"Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors","volume":"7","author":"Mills","year":"2006","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.06.001_bib0410","doi-asserted-by":"crossref","first-page":"101610","DOI":"10.1016\/j.esmoop.2023.101610","article-title":"Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2\u00a0study","volume":"8","author":"Charton","year":"2023","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.bulcan.2024.06.001_bib0415","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"524","key":"10.1016\/j.bulcan.2024.06.001_bib0420","first-page":"30","article-title":"Le rapport b\u00e9n\u00e9fice\/risque\u00a0: une notion complexe","volume":"52","year":"2013","journal-title":"Actual Pharm"},{"issue":"7","key":"10.1016\/j.bulcan.2024.06.001_bib0425","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/pds.3636","article-title":"Balancing benefit and risk of medicines: a systematic review and classification of available methodologies","volume":"23","author":"Mt-Isa","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.bulcan.2024.06.001_bib0430","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1177\/0272989X10393976","article-title":"Varieties of uncertainty in health care: a conceptual taxonomy","volume":"31","author":"Han","year":"2011","journal-title":"Med Decis Mak Int J Soc Med Decis Mak"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0435","series-title":"L\u2019incertitude m\u00e9dicale","first-page":"80","author":"Fox","year":"1988"},{"issue":"2","key":"10.1016\/j.bulcan.2024.06.001_bib0440","first-page":"49","article-title":"M\u00e9decine de pr\u00e9cision et Evidence-Based Medicine\u00a0: quelle articulation\u00a0?","volume":"4","author":"Giroux","year":"2017","journal-title":"Lato Sensu Rev Soc Philos Sci"},{"issue":"2","key":"10.1016\/j.bulcan.2024.06.001_bib0445","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jacc.2016.03.600","article-title":"Achievements and limitations of evidence-based medicine","volume":"68","author":"Sheridan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0450","unstructured":"La m\u00e9decine de pr\u00e9cision en oncologie\u00a0: challenges, enjeux et nouveaux paradigmes\u00a0\u2013\u00a0EM consulte [Internet]. [cit\u00e9 5\u00a0juill 2023. Disponible sur\u00a0: https:\/\/www.em-consulte.com\/article\/1276767\/la-medecine-de-precision-en-oncologie%C2\u00a0%A0-challenges-]."},{"key":"10.1016\/j.bulcan.2024.06.001_bib0455","doi-asserted-by":"crossref","first-page":"635422","DOI":"10.3389\/fpsyg.2021.635422","article-title":"Oncologists\u2019 communication about uncertain information in second opinion consultations: a focused qualitative analysis","volume":"12","author":"van Someren","year":"2021","journal-title":"Front Psychol"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0460","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.socscimed.2017.03.024","article-title":"Tolerance of uncertainty: conceptual analysis, integrative model, and implications for healthcare","volume":"180","author":"Hillen","year":"2017","journal-title":"Soc Sci Med"},{"issue":"4","key":"10.1016\/j.bulcan.2024.06.001_bib0465","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1547-5069.1988.tb00082.x","article-title":"Uncertainty in illness","volume":"20","author":"Mishel","year":"1988","journal-title":"Image J Nurs Scholarsh"},{"issue":"4","key":"10.1016\/j.bulcan.2024.06.001_bib0470","first-page":"362","article-title":"Physicians\u2019 attitudes about communicating and managing scientific uncertainty differ by perceived ambiguity aversion of their patients","volume":"16","author":"Portnoy","year":"2013","journal-title":"Health Expect Int J Public Particip Health Care Health Policy"},{"issue":"4","key":"10.1016\/j.bulcan.2024.06.001_bib0475","doi-asserted-by":"crossref","first-page":"E152","DOI":"10.1188\/17.ONF.E152-E167","article-title":"Antecedents and outcomes of uncertainty in older adults with cancer: a scoping review of the literature","volume":"44","author":"Ghodraty Jabloo","year":"2017","journal-title":"Oncol Nurs Forum"},{"issue":"9","key":"10.1016\/j.bulcan.2024.06.001_bib0480","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1002\/cam4.2940","article-title":"Cancer patients\u2019 experiences with immune checkpoint modulators: a qualitative study","volume":"9","author":"Ala-Leppilampi","year":"2020","journal-title":"Cancer Med"},{"issue":"12","key":"10.1016\/j.bulcan.2024.06.001_bib0485","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s11606-007-0416-9","article-title":"\u00ab\u00a0Could this be something serious?\u00a0\u00bb Reassurance, uncertainty, and empathy in response to patients\u2019 expressions of worry","volume":"22","author":"Epstein","year":"2007","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.bulcan.2024.06.001_bib0245","first-page":"1694","article-title":"Comment r\u00e9diger un article scientifique de type revue narrative de la litt\u00e9rature\u00a0?","volume":"664","author":"Saracci","year":"2019","journal-title":"Rev Med Suisse"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455124002595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455124002595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T21:05:30Z","timestamp":1727125530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455124002595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0007455124002595"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.06.001","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Th\u00e9rapies cibl\u00e9es et immunoth\u00e9rapie\u00a0: positionnement dans le champ de l\u2019innovation et enjeux pour le processus de d\u00e9cision th\u00e9rapeutique","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}